St. Louis company strikes deal with Poland for isotope that is crucial to medical tests

Los Angeles Times, February 18, 2010

As U.S. physicians face an impending crisis caused by lack of a crucial isotope used in many diagnostic procedures, a U.S. company said that it had reached an agreement with the Polish nuclear energy agency to obtain the isotope from a reactor in that country, the Los Angeles Times reports. Covidien, a St. Louis company that processes a radioisotope produced by reactors into a form that can be used in the medical tests, said that Poland's Institute of Atomic Energy will provide enough molybdenum-99 from the agency's Maria Research Reactor to meet the needs of about 1 million patients annually.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.